Orion Oyj (OTCMKTS:ORINY) Reaches New 12-Month High at $26.90

Orion Oyj (OTCMKTS:ORINY) shares reached a new 52-week high on Tuesday . The stock traded as high as $26.90 and last traded at $26.90, with a volume of 2513 shares traded. The stock had previously closed at $25.67.

Orion Oyj Stock Down 3.0 %

The firm has a market cap of $7.36 billion, a price-to-earnings ratio of 31.05 and a beta of 0.19. The business’s 50-day moving average is $22.36 and its 200-day moving average is $20.53. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.00 and a current ratio of 1.78.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.